Publications
- Clinical outcomes, immunogenicity, and safety of BNT162b22 Vaccine in Primary Antibody Deficiency2023 | Second Faculty of Medicine
- Encapsulation: A Strategy to Deliver Therapeutics and Bioactive Compounds?2023 | Second Faculty of Medicine
- Content and specificity of the Anti-SARS-CoV-2 antibodies in solutions for immunoglobulin replacement therapy2023 | Second Faculty of Medicine
- Humoral and cellular immune responses to mRNA COVID-19 vaccines in patients with axial spondyloarthritis treated with adalimumab or secukinumab2022 | Second Faculty of Medicine
- Immunogenicity and safety of the booster BNT162b2 vaccine in patients with axial spondyloarthritis treated with biological disease-modifying drugs2022 | Second Faculty of Medicine
- SARS-CoV-2-specific humoral and cellular immune responses to BNT162b2 vaccine in Fibrodysplasia ossificans progressiva patients2022 | Second Faculty of Medicine
- Principles and Challenges in anti-COVID-19 Vaccine Development2021 | Second Faculty of Medicine
- An immunologist's perspective on anti-COVID-19 vaccines2021 | Second Faculty of Medicine
- Principles and new perspectives in the vaccination against SARS-CoV-2 virus2020 | Second Faculty of Medicine
- Oncostatin M and Nivolumab Affect the Cytotoxic T-Cell Proportions and the Susceptibility to TRAIL-Induced Death in Non-Leukocyte Cell Subpopulations in Soft Tissue Sarcomas2023 | Second Faculty of Medicine, First Faculty of Medicine, Faculty of Physical Education and Sport
Loading network view...